5 min read
Psychiatry's New Mechanisms Arrived With Side Effects Attached
For seventy years, antipsychotics for schizophrenia acted on dopamine and antidepressants acted on monoamines. The...
Insights on increasing the translational value of your preclinical development program.
Sep 1, 2026by MD Biosciences
For seventy years, antipsychotics for schizophrenia acted on dopamine and antidepressants acted on monoamines. The...
Aug 25, 2026by MD Biosciences
As of August 2026, acute post-surgical pain has an approved non-opioid sodium channel blocker and a second program with...
Aug 18, 2026by MD Biosciences
Peripheral nerve repair occupies an unusual position in translational neuroscience. The biology is more permissive than...
Aug 11, 2026by MD Biosciences
Osteoarthritis is one of the largest unmet needs in pain, and one of the most stubborn translational problems in the...
Aug 4, 2026by MD Biosciences
Most preclinical neuroscience programs are still built around two categories of evidence. Behavior tells you what the...